Moneycontrol PRO
you are here: HomeNewsVivimed labs
vivimed labs
Jump to
96 Results Found
  • Bulk Deals | Equity Intelligence India buys 1% stake in Cupid; Plutus Capital raises holding in Mohini Health Jul 03, 2021 07:59 AM IST

    Bulk Deals | Equity Intelligence India buys 1% stake in Cupid; Plutus Capital raises holding in Mohini Health

    Among other deals, Sunidhi Securities & Finance acquired 10 lakh equity shares of Pricol at Rs 94.05 per share, while Alpha Leon Enterprises LLP purchased 4,22,237 equity shares of Vivimed Labs at Rs 22.65 per share.

  • Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in India May 10, 2021 12:57 PM IST

    Vivimed Labs gets DGHS nod to manufacture, market Favipiravir tablets in India

    Vivimed Labs in receipt of Government of India (DGHS) approval to manufacture and market Favipiravir tablets in the strengths of 200 mg and 400 mg under Vivimed’s own brand name ‘Favulous’ across India, the company said in a regulatory filing.

  • Vivimed Labs shares hit upper circuit on govt nod to manufacture, market Favipiravir tablet to treat COVID-19 May 10, 2021 11:30 AM IST

    Vivimed Labs shares hit upper circuit on govt nod to manufacture, market Favipiravir tablet to treat COVID-19

    Vivimed Labs received Government of India approval to manufacture and market Favipiravir Tablet 200 mg & 400 mg under brand name “Favulous” across India. It is used for the treatment of mild to moderate cases of Covid-19, the company said.

  • Vivimed Labs shares surge 20% on approvals for 3 products Apr 16, 2021 01:33 PM IST

    Vivimed Labs shares surge 20% on approvals for 3 products

    The share touched a 52-week high of Rs 23.62 and a 52-week low of Rs 9.70 on 25 August, 2020 and 27 May, 2020, respectively.

  • Vivimed Labs Standalone December 2020 Net Sales at Rs 62.44 crore, down 0.53% Y-o-Y Feb 16, 2021 01:11 PM IST

    Vivimed Labs Standalone December 2020 Net Sales at Rs 62.44 crore, down 0.53% Y-o-Y

  • Vivimed Labs share price up nearly 5% on approval of products Oct 13, 2020 09:52 AM IST

    Vivimed Labs share price up nearly 5% on approval of products

    The share gained 41 percent in the last 9 months.

  • Vivimed Labs Consolidated June 2019 Net Sales at Rs 344.21 crore, down 4% Y-o-Y Aug 12, 2019 02:53 PM IST

    Vivimed Labs Consolidated June 2019 Net Sales at Rs 344.21 crore, down 4% Y-o-Y

  • Vivimed Labs Standalone June 2019 Net Sales at Rs 59.11 crore, down 4.64% Y-o-Y Aug 12, 2019 02:53 PM IST

    Vivimed Labs Standalone June 2019 Net Sales at Rs 59.11 crore, down 4.64% Y-o-Y

  • Vivimed Labs Consolidated March 2019 Net Sales at Rs 348.08 crore, up 21.87% Y-o-Y May 31, 2019 04:53 PM IST

    Vivimed Labs Consolidated March 2019 Net Sales at Rs 348.08 crore, up 21.87% Y-o-Y

  • Vivimed Labs Standalone March 2019 Net Sales at Rs 74.60 crore, up 9.72% Y-o-Y May 31, 2019 04:50 PM IST

    Vivimed Labs Standalone March 2019 Net Sales at Rs 74.60 crore, up 9.72% Y-o-Y

  • Vivimed Labs Standalone December 2018 Net Sales at Rs 51.72 crore, down 21.51% Y-o-Y Feb 15, 2019 03:51 PM IST

    Vivimed Labs Standalone December 2018 Net Sales at Rs 51.72 crore, down 21.51% Y-o-Y

  • Vivimed Labs Consolidated December 2018 Net Sales at Rs 243.93 crore, down 18.58% Y-o-Y Feb 15, 2019 03:50 PM IST

    Vivimed Labs Consolidated December 2018 Net Sales at Rs 243.93 crore, down 18.58% Y-o-Y

  • Time to bag small & midcaps after recent decline? 15 stocks fall 40-70% since August Nov 16, 2018 09:47 AM IST

    Time to bag small & midcaps after recent decline? 15 stocks fall 40-70% since August

    Selling in some small & mid-cap stocks started in the beginning of 2018 also —thanks to high valuations, but the pressure increased further post August

  • Vivimed Labs Standalone September 2018 Net Sales at Rs 63.50 crore, up 3.86% Y-o-Y Nov 15, 2018 04:29 PM IST

    Vivimed Labs Standalone September 2018 Net Sales at Rs 63.50 crore, up 3.86% Y-o-Y

  • Vivimed Labs Consolidated September 2018 Net Sales at Rs 364.62 crore, Up 29.07% Y-o-Y. Nov 15, 2018 04:26 PM IST

    Vivimed Labs Consolidated September 2018 Net Sales at Rs 364.62 crore, Up 29.07% Y-o-Y.

  • Vivimed Labs receives EIR from USFDA for Mexico facility Oct 05, 2018 11:25 AM IST

    Vivimed Labs receives EIR from USFDA for Mexico facility

    "The company's API manufacturing facility located in CUERNAVACA, Mexico was recently inspected by the United States Food and Drug Administration (USFDA) in compliance with their requirements," Vivimed Labs said in a BSE filing.

  • Vivimed Labs gets additional $7.5 mn funding from OrbiMed Asia Jan 01, 2018 01:55 PM IST

    Vivimed Labs gets additional $7.5 mn funding from OrbiMed Asia

    The company had earlier received USD 42.5 million from OrbiMed Asia in September 2017, Vivimed Labs said in a BSE filing.

  • Will use funds to augment capacity, reduce debt: Vivimed Labs Sep 29, 2017 12:16 PM IST

    Will use funds to augment capacity, reduce debt: Vivimed Labs

    Healthcare firm Orbimed Asia will invest USD 42.5 million in Vivimed Labs's subsidiary UQUIFA. In an interview to CNBC-TV18, Santosh Varalwar, CMD of Vivimed Labs spoke at length about the same.

  • OrbiMed Asia invests $42.5 mn in Vivimed's API business UQUIFA Sep 26, 2017 11:20 AM IST

    OrbiMed Asia invests $42.5 mn in Vivimed's API business UQUIFA

    Vivimed Labs Mascarene Ltd is the holding entity of the company's API (active pharmaceutical ingredient) business -- UQUIFA. In 2011, Hyderabad-based Vivimed Labs had acquired UQUIFA for USD 55 million.

  • Vivimed Labs zooms 8% on zero US FDA observations for Spain facility Jun 07, 2017 11:06 AM IST

    Vivimed Labs zooms 8% on zero US FDA observations for Spain facility

    After successful inspection, the US Food and Drug Administration has issued zero 483 observations for Spain facility.

  • Strides in JV pact with Vivimed, eyes bigger US generics play May 18, 2017 05:55 PM IST

    Strides in JV pact with Vivimed, eyes bigger US generics play

    The JV allows Strides to get access to Vivimed’s US FDA compliant formulation plant in Alathur, Tamil Nadu in addition to a portfolio of approved abbreviated new drug applications (ANDAs) and under development product pipeline for US market.

  • Vivimed Labs looking to grow US generic market Apr 20, 2017 12:27 PM IST

    Vivimed Labs looking to grow US generic market

    CNBC-TV18 learns from sources that Vivimed Labs is exploring various options to grow its US generics market and selling stake in the Chennai formulation plant.

  • World Bank unit to invest $47.5 mn in Granules India Feb 21, 2017 09:33 AM IST

    World Bank unit to invest $47.5 mn in Granules India

    The company plans to invest a total of around USD 84 million for expansion. Of this, USD 68.5 million will be raised by debt, which includes a loan from World Bank arm International Finance Corporation.

  • Thomas Cook showing signs of improvement: Deven Choksey Feb 15, 2017 09:33 AM IST

    Thomas Cook showing signs of improvement: Deven Choksey

    In an interview to CNBC-TV18, Deven Choksey, MD of KRChoksey Investment Managers shared his readings and outlook on specific stocks that came out with good quarterly numbers.

  • Stocks in news: Tata Motors, DLF, Cadila, JSPL, MOIL, Intellect Feb 15, 2017 08:00 AM IST

    Stocks in news: Tata Motors, DLF, Cadila, JSPL, MOIL, Intellect

    Tata Motors | Sun Pharma | DLF | Cadila Health | Jindal Steel | SpiceJet | Adani Enterprises | MOIL | Cox & Kings | HDIL | Liberty Shoes | Voltas | National Fertilisers | Ashiana Housing | Power Mech | Intellect Design Arena are stocks, which are in the news today.

Sections
ISO 27001 - BSI Assurance Mark